-
Deferasirox Fe3+ Chelate: Redefining Iron Overload Research
2026-05-19
This thought-leadership article explores how Deferasirox Fe3+ chelate (Exjade) is transforming translational research in iron overload, particularly in beta-thalassemia and chronic anemia. Blending mechanistic insight—centered on mitochondrial ROS, NF-κB modulation, and myeloid differentiation—with practical protocol guidance, it offers researchers a strategic roadmap for experimental design and clinical translation. The article highlights APExBIO’s high-purity, DMSO-soluble Deferasirox Fe3+ chelate as the gold standard for advanced iron chelation research, and positions this discussion as a bridge between established literature and future innovation.
-
EdU Flow Cytometry Assay Kits (Cy5): Practical Workflow Guid
2026-05-19
The EdU Flow Cytometry Assay Kits (Cy5) enable reliable, sensitive detection of cell proliferation by quantifying DNA synthesis during the S-phase, without requiring DNA denaturation. This assay is suitable for researchers needing robust, reproducible flow cytometry–based cell proliferation analysis, but is not intended for applications requiring live-cell tracking or real-time kinetic measurements.
-
TQB3720 Induces Ferroptosis via AR/GPX4 Axis in Prostate Can
2026-05-18
This study identifies the second-generation androgen receptor antagonist TQB3720 as a potent inducer of ferroptosis in prostate cancer by disrupting the AR/SP1–GPX4 axis. The findings offer a mechanistic advance in prostate cancer therapy and provide a rationale for further targeting of ferroptotic pathways in oncological research.
-
Scenario-Driven Best Practices with FLAG tag Peptide (DYKDDD
2026-05-18
This article empowers laboratory scientists to optimize recombinant protein purification and detection by addressing common workflow challenges with the FLAG tag Peptide (DYKDDDDK), SKU A6002. Drawing on validated protocols and real-world scenarios, it demonstrates how this high-purity, highly soluble peptide from APExBIO enhances reproducibility, specificity, and workflow efficiency in demanding cell-based assays.
-
QNZ (EVP4593): Precision NF-κB Inhibition for Translational
2026-05-17
QNZ (EVP4593) is a nanomolar quinazoline derivative that enables robust NF-κB pathway modulation in both inflammation and neurodegenerative disease models. This guide details advanced workflows, troubleshooting strategies, and translational insights to help researchers achieve reproducible results using APExBIO’s QNZ (EVP4593) in complex experimental settings.
-
Monomethyl Auristatin E (MMAE): Precision Antimitotic Payloa
2026-05-16
Monomethyl auristatin E (MMAE) is a potent antimitotic agent used as a cytotoxic payload in antibody-drug conjugates (ADCs) for targeted cancer therapy. MMAE blocks tubulin polymerization, disrupts microtubule dynamics, and achieves sub-nanomolar cytotoxicity in diverse cancer models. APExBIO’s MMAE (SKU A3631) offers high purity and reproducibility, supporting both in vitro and in vivo translational workflows.
-
Establishing Organoids from Breast Adenomyoepithelioma: Meth
2026-05-15
This study presents the first successful establishment and characterization of patient-derived organoids from adenomyoepithelioma (AME) of the breast, a rare neoplasm with poorly understood pathogenesis. The organoid platform closely recapitulates the original tumor’s characteristics and demonstrates potential for preclinical drug sensitivity testing, supporting future research in rare breast tumor biology.
-
Berberrubine Chloride: Applied Cancer Research Workflows
2026-05-15
Berberrubine chloride uniquely empowers researchers to target IMPDH2 in colorectal and lung cancer models with selective, quantifiable inhibition. This article unpacks advanced protocols, troubleshooting strategies, and translational insights for maximizing reproducibility and biological impact in preclinical workflows.
-
EdU Imaging Kits (Cy5): Precision S-Phase DNA Synthesis Dete
2026-05-14
EdU Imaging Kits (Cy5) deliver high-sensitivity, no-denaturation cell proliferation analysis, streamlining workflows in both microscopy and flow cytometry. Their click chemistry approach empowers researchers to capture S-phase events with unmatched clarity and robustness—even in complex experimental settings.
-
Cy5.5 NHS Ester (Non-Sulfonated): Benchmarks in Fluorescence
2026-05-14
Cy5.5 NHS ester (non-sulfonated) is a high-performance near-infrared fluorescent dye for covalent biomolecule labeling. Its robust optical properties and stability enable sensitive in vivo fluorescence imaging and tumor visualization. This article enumerates its action mechanism, supporting evidence, applications, and key protocol parameters.
-
ABCC10-Driven cGAMP Efflux Links Metabolism to Radioresistan
2026-05-13
This study identifies ABCC10 as a novel ATP-dependent exporter of 2'3'-cGAMP in cancer cells, revealing a mechanism that dampens STING-mediated innate immune responses and contributes to radiotherapy resistance. The findings provide new insight into metabolic adaptation in tumors and highlight ABCC10 as both a potential biomarker for radiotherapy response and a therapeutic target.
-
Prevotella copri-Induced IPA Depletion Drives Breast Cancer
2026-05-13
This study reveals that gut Prevotella copri depletes host indole-3-pyruvic acid (IPA), promoting breast cancer by disrupting AMPK signaling via UHRF1 upregulation. The findings provide a mechanistic link between microbial tryptophan metabolism and tumor progression, informing future microbiome and metabolic interventions.
-
HyperFusion High-Fidelity DNA Polymerase: Precision in Neuro
2026-05-12
HyperFusion™ high-fidelity DNA polymerase empowers researchers to achieve rapid, error-free PCR even with challenging GC-rich or long templates. Its superior proofreading activity and inhibitor tolerance streamline cloning, sequencing, and neurogenomic workflows—especially where fidelity is mission-critical.
-
Artemisitene Induces Calcium-Dependent Ferroptosis in Colore
2026-05-12
This study uncovers a novel mechanism by which artemisitene triggers ferroptosis in colorectal cancer cells via disruption of the LSH-EWSR1 interaction and downstream calcium signaling modulation. These findings highlight new therapeutic opportunities targeting noncanonical ferroptosis pathways in treatment-resistant colorectal cancer.
-
Aβ42 Peptide Triggers Microglial Phagocytosis in Alzheimer’s
2026-05-11
Kopec and Carroll (1998) demonstrated that Amyloid β-Peptide (1-42) (Aβ42) fibrils directly stimulate murine microglial phagocytosis in a time- and dose-dependent fashion. This work advanced understanding of microglial immune responses to amyloid pathology and provided evidence for extracellular matrix modulation of Aβ42 uptake, informing experimental strategies in Alzheimer’s disease research.